Our health programs

The MSc (Master of Science) in Health Management & Data intelligence offered by emlyon business school, in partnership with Ecole des Mines de Saint-Etienne, is accessible after a Bachelor minimum (valid diplomas include bac +4 or bac +3). It enables foreign or French students to acquire a high-level, specialized education aimed at the main functions of digital health management.

The emlyon BioPharma track of the Master in Management ("Programme Grande Ecole") is a selective curriculum open to students with a first degree - bachelor's level or above - in biological sciences (microbiology, biochemistry, bioengineering, immunology, pharmacology, …) and are considering a career in the biotechnology sector or the pharmaceutical industry.

This is a 2 year curriculum:

In Year 1, in addition to the many academic options and activities offered by the MiM, the enrolled students have access to a “specialization” track of two courses (48 contact hours) on the economics of the biopharma industry, which is specific to the emlyon BioPharma curriculum.
In Year 2, they may apply for an academic semester in the MSc in Business Administration and Bio-entrepreneurship at Copenhagen Business School (from September to December), before taking part in a “professionalization” track of four dedicated courses (96 contact hours), involving the contributions of scientists, executives and entrepreneurs from research centers, biotech ventures and pharmaceuticals companies.

International direct applications are open to foreign candidates, and to French candidates with, or soon to have, a foreign degree equivalent to at least a Bachelor's degree.

The emlyon BioPharma curriculum benefits from interactions with a vibrant ecosystem.
The school's campus is located in the Gerland district, the epicentre of life sciences in Lyon, a hub of research, development and production for biotechnologies and pharmaceuticals.
It is host to: a range of biotech companies (MaaTPharma, Mablink bioscience, Osivax, …), large healthcare firms (bioMérieux, Boehringer Ingelheim, Sanofi Vaccines, …), contract research entities (ABL, Antineo, Anaquant, …), innovation and coordination entities (Bioaster, CLARA, Lyonbiopole, …), international organizations (IARC and WHO Academy), all located in the nearby.